61 results about "Ear infection" patented technology

The present application concerns a device for measurement and analysis of the middle ear and ear channel color for the diagnosis of ear infections. The device is composed of a otoscope (1), including two optical fibers (2a and 2b): one for ear illumination and another returning the reflected light. The electronic unit (3) can change linearly the power of emitted light, as well as, its color. The received light is also independently measured, enabling the determination of changes on color and texture associated with the ear inflammations. Command buttons in the otoscope handler (4) enable the user to save the values of the three color components. The combined value of the components is shown in the digital display (5) of the electronic unit, as well as, by a set of LEDs (6) green, yellow and red that gives a diagnosis in a simple and immediate way. The otoscope allows, simultaneously, directly ear view through a magnifying glass (7) applied in the head of the otoscope, with a standard white light. This device is also useful in food industry.

The present invention relates in its broadest aspect to combined phage / antibiotic therapy. More particularly, it relates to use of (i) one or more bacteriophages and (ii) one or more antibiotics in the manufacture of a combined product for simultaneous, separate or sequential administration of (i) and (ii) to treat a bacterial infection characterized by biofilm formation, for example an infection comprising or consisting of P. aeruginosa. Treatment in this context may be either therapeutic or prophylactic treatment. Also provided are deposited bacteriophages each exhibiting different strain specificity against P. aeruginosa and combinations of such bacteriophages, e.g. a panel of six deposited bacteriophages which was found to be effective against a high percentage of clinical isolates of P. aeruginosa from canine ear infections.

Optical ear infection treatment device and methods are described where an LED and optical light pipe are used to deliver the light from the LED to the middle ear of a patient to reduce bacterial growth and / or eliminate bacteria. Typically, the device is placed in the ear and then activated by the user by pressing an activation button. Once activated the control electronics will turn on the LED and perform a treatment. The most basic treatment mode comprises turning on the LED at maximum power for a predetermined period, e.g. 30 minutes, 60 minutes. When the preset duration is completed, the device will notify the user by an audible beep or vibration that the treatment is complete. Once completed the user can remove the device, the treatment could be repeated once a day or for extreme cases multiple times during the day.

The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.

The present invention relates to the treatment of Otitis or other type ear infections with the use of blue / violet light positioned to shine into the ear canal. The treatment quickly clears up infections and reduces the reoccurrence of ear infections.

Efflux pump inhibitors are co-administered with antimicrobial agents for the treatment of ophthalmic or otic infections. The agents may be co-administered directly to the site of infection (e.g., the eye or ear).

The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin / low molecular weight heparin derivative.

The present invention relates to a formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an antibiotic, and antifungal, and an anti-inflammatory in a thick, otic carrier. In one embodiment, the formulation comprises a therapeutically effective amount of active ingredients including a fluoroquinolone, a triazole antifungal, a thiocarbamate antifungal, a corticosteroid and a polyene antifungal, as well as a thickener such that the formulation, upon applying to the infected ear canal, gels and remains in the ear canal, continuously releasing the active ingredients for several days, achieving consistent complete (98-100%) clinical resolution of otomycosis and otitis externa in a single application.

The present invention relates generally to a methods of treating ear infections and clearing excess fluid from Eustachian tubes.